(RTTNews) - Tactile Systems Technology, Inc. (TCMD), Wednesday announced positive disease-specific health-related quality of life endpoints in a study of Flexitouch advanced pneumatic compression device in veterans with lower extremity lymphedema.
The 52-week study was published in the Journal of Vascular Surgery, Venous and Lymphatic Disorders.
The secondary outcome measures assessed limb circumference, cellulitis events, skin quality, and therapy compliance over the course of 52 weeks.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
